Renal transplantation at Oregon Health and Science University

recent results and protocols.

Muralikrishna Golconda, Angelo M DeMattos, Jonathan Prather, Ali J. Olyaei, Lori Fletcher, Mary Ann Head, Paula Wetzsteon, John M. Barry, Douglas J. Norman

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Renal transplants have been performed at the University Hospital, Portland, OR since 1959. In the 5-year period between January 1997 and December 2001, 736 kidney-only transplants were performed at our institution. Living donor transplants comprise an increasing proportion of the transplants performed. Our patient and graft survival rates, both short- and long-term reflect the close collaboration between the transplantation medicine and transplantation surgery faculties, and the excellent support from nurse-coordinators, histocompatibility laboratory specialists and the organ procurement organization. Since September 2001, we have used a risk-based immunosuppression algorithm. The incidence of acute rejection within the first 3 months following transplantation ranged from 7-18% in the different risk groups. We have incorporated surveillance renal allograft biopsies into our standard of care and biopsies are performed at 3 months and one year after transplantation. The incidence of subclinical rejection was 15% on the 3-month surveillance biopsies and 4% on the one-year biopsies. The majority of these rejection episodes were CCTT type I acute rejection, which responded to treatment with pulse steroids. Since 1991, we have been transplanting kidneys from blood group A2 donors into blood group B or O recipients. Graft survival is similar to that in patients receiving an ABO compatible transplant. We have recently adopted the use of intravenous immune globulin to abrogate a positive crossmatch and allow transplantation of a kidney from a living donor. Six patients have been successfully transplanted using this protocol. In an effort to speed up the work-up of recipients waiting for a deceased donor kidney transplant, we have implemented a computer-driven algorithm. By generating a list of patients who should be crossmatched, and by automating generation of work sheets and reports, this computer-driven program has expedited deceased donor workups.

Original languageEnglish (US)
Pages (from-to)149-154
Number of pages6
JournalClinical transplants
StatePublished - 2003
Externally publishedYes

Fingerprint

Kidney Transplantation
Transplants
Kidney
Health
Transplantation
Biopsy
Living Donors
Tissue Donors
Graft Survival
Blood Group Antigens
Histocompatibility
Tissue and Organ Procurement
Intravenous Immunoglobulins
Incidence
Standard of Care
varespladib methyl
Immunosuppression
Allografts
Software
Survival Rate

Cite this

Golconda, M., DeMattos, A. M., Prather, J., Olyaei, A. J., Fletcher, L., Head, M. A., ... Norman, D. J. (2003). Renal transplantation at Oregon Health and Science University: recent results and protocols. Clinical transplants, 149-154.

Renal transplantation at Oregon Health and Science University : recent results and protocols. / Golconda, Muralikrishna; DeMattos, Angelo M; Prather, Jonathan; Olyaei, Ali J.; Fletcher, Lori; Head, Mary Ann; Wetzsteon, Paula; Barry, John M.; Norman, Douglas J.

In: Clinical transplants, 2003, p. 149-154.

Research output: Contribution to journalArticle

Golconda, M, DeMattos, AM, Prather, J, Olyaei, AJ, Fletcher, L, Head, MA, Wetzsteon, P, Barry, JM & Norman, DJ 2003, 'Renal transplantation at Oregon Health and Science University: recent results and protocols.', Clinical transplants, pp. 149-154.
Golconda, Muralikrishna ; DeMattos, Angelo M ; Prather, Jonathan ; Olyaei, Ali J. ; Fletcher, Lori ; Head, Mary Ann ; Wetzsteon, Paula ; Barry, John M. ; Norman, Douglas J. / Renal transplantation at Oregon Health and Science University : recent results and protocols. In: Clinical transplants. 2003 ; pp. 149-154.
@article{a986611d22d5440384daa3aa25a578b2,
title = "Renal transplantation at Oregon Health and Science University: recent results and protocols.",
abstract = "Renal transplants have been performed at the University Hospital, Portland, OR since 1959. In the 5-year period between January 1997 and December 2001, 736 kidney-only transplants were performed at our institution. Living donor transplants comprise an increasing proportion of the transplants performed. Our patient and graft survival rates, both short- and long-term reflect the close collaboration between the transplantation medicine and transplantation surgery faculties, and the excellent support from nurse-coordinators, histocompatibility laboratory specialists and the organ procurement organization. Since September 2001, we have used a risk-based immunosuppression algorithm. The incidence of acute rejection within the first 3 months following transplantation ranged from 7-18{\%} in the different risk groups. We have incorporated surveillance renal allograft biopsies into our standard of care and biopsies are performed at 3 months and one year after transplantation. The incidence of subclinical rejection was 15{\%} on the 3-month surveillance biopsies and 4{\%} on the one-year biopsies. The majority of these rejection episodes were CCTT type I acute rejection, which responded to treatment with pulse steroids. Since 1991, we have been transplanting kidneys from blood group A2 donors into blood group B or O recipients. Graft survival is similar to that in patients receiving an ABO compatible transplant. We have recently adopted the use of intravenous immune globulin to abrogate a positive crossmatch and allow transplantation of a kidney from a living donor. Six patients have been successfully transplanted using this protocol. In an effort to speed up the work-up of recipients waiting for a deceased donor kidney transplant, we have implemented a computer-driven algorithm. By generating a list of patients who should be crossmatched, and by automating generation of work sheets and reports, this computer-driven program has expedited deceased donor workups.",
author = "Muralikrishna Golconda and DeMattos, {Angelo M} and Jonathan Prather and Olyaei, {Ali J.} and Lori Fletcher and Head, {Mary Ann} and Paula Wetzsteon and Barry, {John M.} and Norman, {Douglas J.}",
year = "2003",
language = "English (US)",
pages = "149--154",
journal = "Clinical transplants",
issn = "0890-9016",
publisher = "UCLA Immunogenetics Center",

}

TY - JOUR

T1 - Renal transplantation at Oregon Health and Science University

T2 - recent results and protocols.

AU - Golconda, Muralikrishna

AU - DeMattos, Angelo M

AU - Prather, Jonathan

AU - Olyaei, Ali J.

AU - Fletcher, Lori

AU - Head, Mary Ann

AU - Wetzsteon, Paula

AU - Barry, John M.

AU - Norman, Douglas J.

PY - 2003

Y1 - 2003

N2 - Renal transplants have been performed at the University Hospital, Portland, OR since 1959. In the 5-year period between January 1997 and December 2001, 736 kidney-only transplants were performed at our institution. Living donor transplants comprise an increasing proportion of the transplants performed. Our patient and graft survival rates, both short- and long-term reflect the close collaboration between the transplantation medicine and transplantation surgery faculties, and the excellent support from nurse-coordinators, histocompatibility laboratory specialists and the organ procurement organization. Since September 2001, we have used a risk-based immunosuppression algorithm. The incidence of acute rejection within the first 3 months following transplantation ranged from 7-18% in the different risk groups. We have incorporated surveillance renal allograft biopsies into our standard of care and biopsies are performed at 3 months and one year after transplantation. The incidence of subclinical rejection was 15% on the 3-month surveillance biopsies and 4% on the one-year biopsies. The majority of these rejection episodes were CCTT type I acute rejection, which responded to treatment with pulse steroids. Since 1991, we have been transplanting kidneys from blood group A2 donors into blood group B or O recipients. Graft survival is similar to that in patients receiving an ABO compatible transplant. We have recently adopted the use of intravenous immune globulin to abrogate a positive crossmatch and allow transplantation of a kidney from a living donor. Six patients have been successfully transplanted using this protocol. In an effort to speed up the work-up of recipients waiting for a deceased donor kidney transplant, we have implemented a computer-driven algorithm. By generating a list of patients who should be crossmatched, and by automating generation of work sheets and reports, this computer-driven program has expedited deceased donor workups.

AB - Renal transplants have been performed at the University Hospital, Portland, OR since 1959. In the 5-year period between January 1997 and December 2001, 736 kidney-only transplants were performed at our institution. Living donor transplants comprise an increasing proportion of the transplants performed. Our patient and graft survival rates, both short- and long-term reflect the close collaboration between the transplantation medicine and transplantation surgery faculties, and the excellent support from nurse-coordinators, histocompatibility laboratory specialists and the organ procurement organization. Since September 2001, we have used a risk-based immunosuppression algorithm. The incidence of acute rejection within the first 3 months following transplantation ranged from 7-18% in the different risk groups. We have incorporated surveillance renal allograft biopsies into our standard of care and biopsies are performed at 3 months and one year after transplantation. The incidence of subclinical rejection was 15% on the 3-month surveillance biopsies and 4% on the one-year biopsies. The majority of these rejection episodes were CCTT type I acute rejection, which responded to treatment with pulse steroids. Since 1991, we have been transplanting kidneys from blood group A2 donors into blood group B or O recipients. Graft survival is similar to that in patients receiving an ABO compatible transplant. We have recently adopted the use of intravenous immune globulin to abrogate a positive crossmatch and allow transplantation of a kidney from a living donor. Six patients have been successfully transplanted using this protocol. In an effort to speed up the work-up of recipients waiting for a deceased donor kidney transplant, we have implemented a computer-driven algorithm. By generating a list of patients who should be crossmatched, and by automating generation of work sheets and reports, this computer-driven program has expedited deceased donor workups.

UR - http://www.scopus.com/inward/record.url?scp=4644362761&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=4644362761&partnerID=8YFLogxK

M3 - Article

SP - 149

EP - 154

JO - Clinical transplants

JF - Clinical transplants

SN - 0890-9016

ER -